Terms: = Brain cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
3145 results:
1. Predictors of early and late postoperative seizures in meningioma patients: a systematic review and meta-analysis.
Ghazou A; Yassin A; Aljabali AS; Al-Zamer YS; Alawajneh M; Al-Akhras A; AlBarakat MM; Tashtoush S; Shammout O; Al-Horani SS; Jarrah EE; Ababneh O; Jaradat A
Neurosurg Rev; 2024 May; 47(1):242. PubMed ID: 38806755
[TBL] [Abstract] [Full Text] [Related]
2. Brachytherapy in craniopharyngiomas: a systematic review and meta-analysis of long-term follow-up.
Zhang LY; Guo W; Du HZ; Pan H; Sun YC; Zhu HJ; Song SH; Guo XY; Jiang Y; Sun QQ
BMC Cancer; 2024 May; 24(1):637. PubMed ID: 38790011
[TBL] [Abstract] [Full Text] [Related]
3. Epidemiology of primary brain tumor among adolescents and adults in Palestine: a retrospective study from 2018 to 2023.
Abuawad M; Daqour A; Alkaiyat A; Rjoub A; Zahra WA; Issa N; Dumaidi Y; Nasser S
BMC Neurol; 2024 May; 24(1):168. PubMed ID: 38783212
[TBL] [Abstract] [Full Text] [Related]
4. MR-based radiomics predictive modelling of EGFR mutation and HER2 overexpression in metastatic brain adenocarcinoma: a two-centre study.
Li Y; Jin Y; Wang Y; Liu W; Jia W; Wang J
Cancer Imaging; 2024 May; 24(1):65. PubMed ID: 38773634
[TBL] [Abstract] [Full Text] [Related]
5. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
[TBL] [Abstract] [Full Text] [Related]
6. Investigating the role of TGF-β and BDNF in cancer-related depression: a primary cross-sectional study.
Lin J; Xiao L; Nie X; Wang Z; Luo Y; Zhang L; Liu Y
Support Care Cancer; 2024 May; 32(6):365. PubMed ID: 38758235
[TBL] [Abstract] [Full Text] [Related]
7. Long-term outcomes of neuroendoscopic cyst partial resection combined with stereotactic radiotherapy for craniopharyngioma.
Fukuhara N; Nishihara T; Sato K; Inoshita N; Tatsushima K; Yamaguchi-Okada M; Ishojima T; Takeshita A; Ito J; Takeuchi Y; Yamada S; Nishioka H
Acta Neurochir (Wien); 2024 May; 166(1):218. PubMed ID: 38750340
[TBL] [Abstract] [Full Text] [Related]
8. ReMIND: The brain Resection Multimodal Imaging Database.
Juvekar P; Dorent R; Kögl F; Torio E; Barr C; Rigolo L; Galvin C; Jowkar N; Kazi A; Haouchine N; Cheema H; Navab N; Pieper S; Wells WM; Bi WL; Golby A; Frisken S; Kapur T
Sci Data; 2024 May; 11(1):494. PubMed ID: 38744868
[TBL] [Abstract] [Full Text] [Related]
9. Prediction of the treatment response and local failure of patients with brain metastasis treated with stereotactic radiosurgery using machine learning: A systematic review and meta-analysis.
Habibi MA; Rashidi F; Habibzadeh A; Mehrtabar E; Arshadi MR; Mirjani MS
Neurosurg Rev; 2024 Apr; 47(1):199. PubMed ID: 38684566
[TBL] [Abstract] [Full Text] [Related]
10. A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians.
Kumthekar P; Lyleroehr M; Lacson L; Lukas RV; Dixit K; Stupp R; Kruser T; Raizer J; Hou A; Sachdev S; Schwartz M; Pa JB; Lezon R; Schmidt K; Amidei C; Kaiser K
BMC Cancer; 2024 Apr; 24(1):527. PubMed ID: 38664630
[TBL] [Abstract] [Full Text] [Related]
11. A validated LC-MS/MS method for determination of neuro-pharmacokinetic behavior of niraparib in brain tumor patients.
Knight W; Margaryan T; Sanai N; Tovmasyan A
J Pharm Biomed Anal; 2024 Aug; 245():116150. PubMed ID: 38657366
[TBL] [Abstract] [Full Text] [Related]
12. Double pituitary adenomas: report of two cases and systematic review of the literature.
Zhang Y; Gong X; Pu J; Liu J; Ye Z; Zhu H; Lu L; Pan H; Deng K; Yao Y
Front Endocrinol (Lausanne); 2024; 15():1373869. PubMed ID: 38628582
[TBL] [Abstract] [Full Text] [Related]
13. How does deep learning/machine learning perform in comparison to radiologists in distinguishing glioblastomas (or grade IV astrocytomas) from primary CNS lymphomas?: a meta-analysis and systematic review.
Guha A; Halder S; Shinde SH; Gawde J; Munnolli S; Talole S; Goda JS
Clin Radiol; 2024 Jun; 79(6):460-472. PubMed ID: 38614870
[TBL] [Abstract] [Full Text] [Related]
14. cancer-associated point mutations within the extracellular domain of PTPRD affect protein stability and HSPG interaction.
Matsui Y; Imai A; Izumi H; Yasumura M; Makino T; Shimizu T; Sato M; Mori H; Yoshida T
FASEB J; 2024 Apr; 38(7):e23609. PubMed ID: 38593345
[TBL] [Abstract] [Full Text] [Related]
15. Microsurgical removal of supratentorial and cerebellar cavernous malformations: what has changed? A single institution experience.
Meneghelli P; Pasqualin A; Musumeci A; Pinna G; Berti PP; Polizzi GMV; Sinosi FA; Nicolato A; Sala F
J Clin Neurosci; 2024 May; 123():162-170. PubMed ID: 38581776
[TBL] [Abstract] [Full Text] [Related]
16. Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis.
Tsuchiya T; Ikemura M; Miyawaki S; Teranishi Y; Ohara K; Ushiku T; Saito N
Brain Tumor Pathol; 2024 Apr; 41(2):73-79. PubMed ID: 38578531
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of preoperative diffusion restriction in glioblastoma.
Labbène E; Mahmoud M; Marrakchi-Kacem L; Ben Hamouda M
Tunis Med; 2024 Feb; 102(2):94-99. PubMed ID: 38567475
[TBL] [Abstract] [Full Text] [Related]
18. Outcomes of the patients with metastatic male breast cancer.
Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
[TBL] [Abstract] [Full Text] [Related]
19. Volumetric Response and Survival of Patients With Bulky IDH-Mutated Grade 3 Glioma Managed With FET-FDG-Guided Integrated Boost IMRT.
Mills D; Horsley P; Venkatasha V; Back M
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):343-352. PubMed ID: 38553362
[TBL] [Abstract] [Full Text] [Related]
20. A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.
Flores-Paco P; Vargas-Aliaga A; Guevara MG; Lopera I; Ruiz LR; López-Herrero M; Camús JA; López-González J; Inga-Saavedra E; Montero M; Barneto I; Gómez-España MA; Ruiz E; Ruza M; Armenta A; Palacios A; De La Haba-Rodríguez JR; Aranda E
J Neurooncol; 2024 May; 167(3):407-413. PubMed ID: 38539006
[TBL] [Abstract] [Full Text] [Related]
[Next]
